Source: Annual Congress 2008 - Inflammatory biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Fens, M. P. C. van der Schee, S. B. de Nijs, E. Dijkers, E. H. Bel, P. J. Sterk (Amsterdam, Netherlands). Exhaled breath molecular profiling in measuring inflammatory status in COPD. Eur Respir J 2008; 32: Suppl. 52, 1117

Member's Comments

No comment yet.

Related content which might interest you: Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath Source: ERS Lung Science Conference 2016 Year: 2016 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Exhaled breath condensate eicosanoids as markers of asthma severity Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Exhaled breath CO and induced sputum in noninvasive assessment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Exhaled breath analysis using eNose technology in patients with sarcoidosis Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020 Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011